Citadel Advisors - APRICUS BIOSCIENCES INC ownership

APRICUS BIOSCIENCES INC's ticker is APRI and the CUSIP is 03832V307. A total of 30 filers reported holding APRICUS BIOSCIENCES INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of APRICUS BIOSCIENCES INC
ValueSharesWeighting
Q4 2018$24,000
+100.0%
125,346
+230.9%
0.00%
Q3 2018$12,000
-81.0%
37,881
-75.7%
0.00%
Q1 2018$63,000
+186.4%
156,107
+1188.1%
0.00%
Q4 2017$22,000
-4.3%
12,119
-11.6%
0.00%
Q3 2017$23,000
+35.3%
13,711
-9.3%
0.00%
Q2 2017$17,000
-74.6%
15,122
-52.7%
0.00%
Q1 2017$67,00031,9690.00%
Other shareholders
APRICUS BIOSCIENCES INC shareholders Q3 2018
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 4,600,000$1,426,0000.09%
Healthcare Value Capital, LLC 100,000$31,0000.08%
ARDSLEY ADVISORY PARTNERS LP 100,000$31,0000.00%
WealthShield Partners, LLC 10,000$3,0000.00%
Frontier Wealth Management LLC 20,000$6,0000.00%
Virtu Financial LLC 47,740$15,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 2,415$1,0000.00%
Blume Capital Management, Inc. 3$00.00%
COLONY GROUP LLC 10,000$3,0000.00%
UBS Group AG 6,772$2,0000.00%
View complete list of APRICUS BIOSCIENCES INC shareholders